botulism [Clostridium botulinum] [serotype A, B, C, D, E, F, G] (heptavalent) antitoxin [equine]

Trials studying botulism [Clostridium botulinum] [serotype A, B, C, D, E, F, G] (heptavalent) antitoxin [equine]

• phase3A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatmentrecruitingn=70
• phase2Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.active not recruitingn=33
• phase2A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)completedn=40
• phase3Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)completedn=238
• phase2Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edemacompletedn=60
• EP1Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.recruitingn=20
• phase3A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatmentactive not recruitingn=327
• phase1Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjectscompletedn=300